Medicines and Therapies

A new roadside drug-testing regime may see law-abiding citizens with legal prescriptions barred from driving for a period of 12 hours, reports Jody Hopkinson

A new roadside drug-testing regime may see law-abiding citizens with legal prescriptions barred from driving for a period of 12 hours, reports Jody Hopkinson

Medicines reclassification expert Natalie Gauld asked pharmacists for help in tracking down motor neurone disease, reports Jody Hopkinson

Healthcare Handbook editor and clinical pharmacist Carmen Pope explains how you can increase the number of people attempting to quit smoking, and how to increase the chances of quit attempts succeeding

Clinical writer Noni Richards discusses the effective management of upper respiratory tract infections, including symptom assessment, patient education, appropriate product recommendations and preventive strategies

Douglas Pharmaceuticals, New Zealand’s largest privately owned pharmaceutical company, announces the launch of Winlevi® (clascoterone cream 1%) following regulatory approval by Medsafe.¹ Winlevi® provides healthcare professionals with a novel topical treatment for patients aged 12 years and older with acne vulgaris

Clinical writer Noni Richards summarises the assessment, treatment and prevention of urinary tract infections

Healthcare Handbook editor and clinical pharmacist Carmen Pope reviews the prevention and management of migraines

Gastroenterologist Cameron Schauer describes the symptoms, consequences and multimodal treatment of reflux – from lifestyle interventions to medications and surgery

Recently returned from three weeks riding on South Island bike trails on her three-wheel bike, pioneering pharmacist Natalie Gauld is asking pharmacists to share a survey she’s leading on the impacts of motor neurone disease for those with it, their family members and those recently bereaved by MND.